Skip to content

Universal Health Services

NYSE: UHS · USD

Universal Health Services cash flow and EPS83

Operating cash flow, capital investment, free cash flow and earnings per share.

Capital allocation

% of tracked cash uses

$717.185M
Universal Health Services capital allocation. Quarterly values. Missing values are unavailable.
PeriodCapexAcquisitionsBuybacksDividendsDebt repaymentsTracked uses
FY 2012 Q154.34% · $92.563MUnavailable1.18% · $2.017M2.84% · $4.832M41.64% · $70.942M100% · $170.354M
FY 2012 Q240.76% · $89.788MUnavailable0.41% · $0.91M2.2% · $4.841M56.63% · $124.744M100% · $220.283M
FY 2012 Q39.44% · $99.84M1.29% · $13.616M0.64% · $6.749M0.46% · $4.846M88.17% · $932.143M100% · $1,057.194M
FY 2012 Q412.71% · $81.001M78.91% · $502.755M1.49% · $9.478M6.89% · $43.876MUnavailable100% · $637.11M
FY 2013 Q151.92% · $95.919M0% · $0M7.59% · $14.027M2.64% · $4.87M37.85% · $69.926M100% · $184.742M
FY 2013 Q236.41% · $80.025M0.6% · $1.32M3.34% · $7.346M2.24% · $4.925M57.41% · $126.17M100% · $219.786M
FY 2013 Q370.3% · $103.807M0% · $0M0.55% · $0.813M3.33% · $4.911M25.83% · $38.135M100% · $147.666M
FY 2013 Q425.73% · $78.742M3.7% · $11.316M1.64% · $5.015M1.61% · $4.915M67.32% · $205.993M100% · $305.981M
FY 2014 Q141.31% · $92.387M1.48% · $3.301M6.26% · $13.993M2.21% · $4.933M48.76% · $109.054M100% · $223.668M
FY 2014 Q236.46% · $94.399M26.15% · $67.699M8.41% · $21.78M1.91% · $4.951M27.07% · $70.072M100% · $258.901M
FY 2014 Q310.61% · $122.575M28.7% · $331.405M2.38% · $27.519M0.86% · $9.91M57.45% · $663.417M100% · $1,154.826M
FY 2014 Q442.01% · $81.789M14.89% · $28.981M19.24% · $37.457M5.07% · $9.871M18.79% · $36.586M100% · $194.684M
FY 2015 Q127.78% · $89.276M10.74% · $34.5M8.95% · $28.767M3.08% · $9.899M49.44% · $158.871M100% · $321.313M
FY 2015 Q235.76% · $81.304M0% · $0M17.32% · $39.39M4.36% · $9.905M42.57% · $96.787M100% · $227.386M
FY 2015 Q331.01% · $98.998M46.56% · $148.603M19.33% · $61.705M3.1% · $9.892MUnavailable100% · $319.198M
FY 2015 Q419.95% · $109.743M63.73% · $350.552M14.53% · $79.92M1.79% · $9.836MUnavailable100% · $550.051M
FY 2016 Q125.74% · $127.214M3.95% · $19.543M34.61% · $171.042M1.97% · $9.757M33.72% · $166.671M100% · $494.227M
FY 2016 Q213.65% · $120.501M0.9% · $7.982M7.71% · $68.097M1.1% · $9.727M76.64% · $676.68M100% · $882.987M
FY 2016 Q345.69% · $148.448M33.46% · $108.696M17.86% · $58.038M2.99% · $9.713MUnavailable100% · $324.895M
FY 2016 Q418.55% · $123.776M71.58% · $477.582M8.42% · $56.203M1.45% · $9.678MUnavailable100% · $667.239M
FY 2017 Q131.27% · $144.338M3.86% · $17.832M6.32% · $29.167M2.09% · $9.662M56.46% · $260.633M100% · $461.632M
FY 2017 Q247.66% · $118.114M0.72% · $1.778M47.74% · $118.296M3.88% · $9.618MUnavailable100% · $247.806M
FY 2017 Q343.52% · $156.241M0% · $0M26.58% · $95.407M2.65% · $9.496M27.26% · $97.851M100% · $358.995M
FY 2017 Q450.84% · $138.813M1.2% · $3.268M44.51% · $121.531M3.46% · $9.435MUnavailable100% · $273.047M
FY 2018 Q151.16% · $189.041M5.66% · $20.931M2.55% · $9.441M2.55% · $9.422M38.07% · $140.676M100% · $369.511M
FY 2018 Q257.36% · $181.211M0% · $0M39.67% · $125.343M2.97% · $9.382MUnavailable100% · $315.936M
FY 2018 Q338.6% · $151.097M22.25% · $87.085M32.31% · $126.472M2.37% · $9.282M4.47% · $17.499M100% · $391.435M
FY 2018 Q414.05% · $143.613M0.24% · $2.448M13.32% · $136.169M0.91% · $9.256M71.48% · $730.527M100% · $1,022.013M
FY 2019 Q138.84% · $169.848M0% · $0M32.88% · $143.785M2.08% · $9.081M26.2% · $114.54M100% · $437.254M
FY 2019 Q229.99% · $154.072M0% · $0M68.29% · $350.864M1.73% · $8.872MUnavailable100% · $513.808M
FY 2019 Q350.95% · $156.327M0% · $0M30.42% · $93.327M5.74% · $17.603M12.89% · $39.558M100% · $306.815M
FY 2019 Q442.52% · $153.848M2.21% · $8.005M50.45% · $182.528M4.82% · $17.447MUnavailable100% · $361.828M
FY 2020 Q132.96% · $184.102MUnavailable30.81% · $172.092M3.1% · $17.344M33.13% · $185.098M100% · $558.636M
FY 2020 Q236.07% · $170.508MUnavailable5.92% · $27.962M0% · $0M58.01% · $274.234M100% · $472.704M
FY 2020 Q320.06% · $192.046M5.33% · $51.041M0% · $0.044M0% · $0M74.6% · $714.258M100% · $957.389M
FY 2020 Q496.54% · $184.651M0% · $0M3.46% · $6.621M0% · $0MUnavailable100% · $191.272M
FY 2021 Q147.25% · $247.459MUnavailable1.43% · $7.464M3.25% · $17.018M48.08% · $251.83M100% · $523.771M
FY 2021 Q236.73% · $234.752MUnavailable56.42% · $360.616M2.63% · $16.826M4.22% · $26.955M100% · $639.149M
FY 2021 Q35.49% · $183.814MUnavailable12.01% · $402.585M0.49% · $16.44M82.01% · $2,748.103M100% · $3,350.942M
FY 2021 Q425.89% · $189.634M9.01% · $66.024M61.47% · $450.21M2.13% · $15.612M1.5% · $10.98M100% · $732.46M
FY 2022 Q133.76% · $200.002MUnavailable61.7% · $365.505M2.51% · $14.875M2.02% · $11.966M100% · $592.348M
FY 2022 Q232.63% · $207.96MUnavailable31.33% · $199.677M2.32% · $14.766M33.72% · $214.888M100% · $637.291M
FY 2022 Q347.45% · $161.593M1.82% · $6.181M46.46% · $158.202M4.27% · $14.551MUnavailable100% · $340.527M
FY 2022 Q456.73% · $164.446M0.57% · $1.643M37.79% · $109.534M4.92% · $14.257MUnavailable100% · $289.88M
FY 2023 Q159.32% · $168.752MUnavailable29.89% · $85.039M5% · $14.214M5.8% · $16.489M100% · $284.494M
FY 2023 Q243.76% · $167.912MUnavailable32.5% · $124.717M3.66% · $14.049M20.08% · $77.068M100% · $383.746M
FY 2023 Q351.38% · $200.001M0% · $0M45.1% · $175.583M3.52% · $13.701MUnavailable100% · $389.285M
FY 2023 Q449.92% · $206.39M0% · $0M39.19% · $162.024M3.27% · $13.516M7.61% · $31.471M100% · $413.401M
FY 2024 Q148.71% · $208.539MUnavailable33.19% · $142.084M3.18% · $13.601M14.93% · $63.905M100% · $428.129M
FY 2024 Q236.06% · $241.394MUnavailable14.33% · $95.903M2% · $13.405M47.62% · $318.77M100% · $669.472M
FY 2024 Q39.79% · $247.932MUnavailable7.21% · $182.601M0.52% · $13.296M82.48% · $2,088.84M100% · $2,532.669M
FY 2024 Q435.3% · $245.945M2.73% · $18.998M35.91% · $250.166M1.87% · $13.044M24.19% · $168.486M100% · $696.639M
FY 2025 Q148.45% · $239.026M1.69% · $8.314M45.28% · $223.385M2.74% · $13.534M1.85% · $9.113M100% · $493.372M
FY 2025 Q259.98% · $266.014M0% · $0M34.98% · $155.157M2.91% · $12.9M2.13% · $9.435M100% · $443.506M
FY 2025 Q343.4% · $228.892M7.48% · $39.458M45.01% · $237.399M2.36% · $12.468M1.75% · $9.243M100% · $527.46M
FY 2025 Q442.52% · $281.22M0% · $0.032M53.23% · $352.01M1.87% · $12.365M2.38% · $15.713M100% · $661.34M
FY 2026 Q148.96% · $217.157M1.09% · $4.857M36.94% · $163.849M2.92% · $12.974M10.08% · $44.731M100% · $443.568M
FY 2026 Q231.74% · $227.633M0% · $0M44.72% · $320.752M1.64% · $11.786M21.89% · $157.014M100% · $717.185M
Dec 31, 2011 through Jun 30, 2026

Operating cash flow

USD millions

$443.303M

Capital expenditures

USD millions

$227.633M

Free cash flow

USD millions

$215.67M

Stock-based compensation

USD millions

$22.909M

SBC / free cash flow

% · FCF before SBC deduction

10.62%

SBC / operating cash flow

%

5.17%

Software & intangible investment

USD millions

—

Separately disclosed software and intangible investment is unavailable in the extracted statements for this period.

Diluted EPS

USD per share

$5.98

Quarterly data

Universal Health Services cash-flow history. Each metric has its own unit. A dash means inputs are missing or the calculation is undefined.
Fiscal periodEndedOperating cash flowUSD millionsCapital expendituresUSD millionsFree cash flowUSD millionsStock-based compensationUSD millionsSBC / free cash flow%SBC / operating cash flow%Software & intangible investmentUSD millionsDiluted EPSUSD per share
FY 2026 Q2Jun 30, 2026443.3227.63215.6722.9110.62%5.17%—$5.98
FY 2026 Q1Mar 31, 2026401.63217.16184.4722.512.2%5.6%—$5.65
FY 2025 Q4Dec 31, 2025574.69281.22293.4725.18.55%4.37%——
FY 2025 Q3Sep 30, 2025380.68228.89151.7924.8816.39%6.54%—$5.86
FY 2025 Q2Jun 30, 2025548.98266.01282.9624.118.52%4.39%—$5.43
FY 2025 Q1Mar 31, 2025360.05239.03121.0221.617.84%6%—$4.8
FY 2024 Q4Dec 31, 2024658.44245.95412.4926.626.45%4.04%——
FY 2024 Q3Sep 30, 2024332.98247.9385.0426.5731.24%7.98%—$3.8
FY 2024 Q2Jun 30, 2024679.28241.39437.8926.536.06%3.91%—$4.26
FY 2024 Q1Mar 31, 2024396.41208.54187.8719.6310.45%4.95%—$3.82
FY 2023 Q4Dec 31, 2023452.43206.39246.0422.028.95%4.87%——
FY 2023 Q3Sep 30, 2023161.67200-38.3422.64—14%—$2.4
FY 2023 Q2Jun 30, 2023362.95167.91195.0422.111.33%6.09%—$2.42
FY 2023 Q1Mar 31, 2023290.75168.7512220.9617.18%7.21%—$2.28
FY 2022 Q4Dec 31, 2022297.3164.45132.8622.6417.04%7.61%——
FY 2022 Q3Sep 30, 2022220.67161.5959.0821.135.72%9.56%—$2.5
FY 2022 Q2Jun 30, 202232.61207.96-175.3522.59—69.25%—$2.2
FY 2022 Q1Mar 31, 2022445.43200245.4319.067.76%4.28%—$2.02
FY 2021 Q4Dec 31, 2021322.02189.63132.3918.1413.7%5.63%——
FY 2021 Q3Sep 30, 2021442.23183.81258.4118.527.17%4.19%—$2.6
FY 2021 Q2Jun 30, 202147.65234.75-187.119.01—39.89%—$3.79
FY 2021 Q1Mar 31, 202171.8247.46-175.6618.02—25.1%—$2.43
FY 2020 Q4Dec 31, 2020142.01184.65-42.6415.91—11.2%—$3.6
FY 2020 Q3Sep 30, 2020766.79192.05574.7415.972.78%2.08%—$2.82
FY 2020 Q2Jun 30, 2020949.31170.51778.815.912.04%1.68%—$2.95
FY 2020 Q1Mar 31, 2020502.06184.1317.9618.055.68%3.59%—$1.64
FY 2019 Q4Dec 31, 2019389.16153.85235.3117.267.34%4.44%—$2.79
FY 2019 Q3Sep 30, 2019425.22156.33268.917.496.5%4.11%—$1.1
FY 2019 Q2Jun 30, 2019233.19154.0779.1117.0921.6%7.33%—$2.66
FY 2019 Q1Mar 31, 2019390.9169.85221.0517.597.96%4.5%—$2.57
FY 2018 Q4Dec 31, 2018365.41143.61221.7915.947.19%4.36%—$1.7
FY 2018 Q3Sep 30, 2018346.23151.1195.1315.938.16%4.6%—$1.84
FY 2018 Q2Jun 30, 2018265.21181.218415.0217.88%5.66%—$2.39
FY 2018 Q1Mar 31, 2018364.05189.04175.0119.711.26%5.41%—$2.36
FY 2017 Q4Dec 31, 2017304.32138.81165.513.98.4%4.57%—$2.31
FY 2017 Q3Sep 30, 2017344.67156.24188.4313.797.32%4%—$1.47
FY 2017 Q2Jun 30, 201750.58118.11-67.5313.71—27.09%—$1.91
FY 2017 Q1Mar 31, 2017483.01144.34338.6715.354.53%3.18%—$2.12
FY 2016 Q4Dec 31, 2016188.37123.7864.5911.7518.19%6.24%—$1.78
FY 2016 Q3Sep 30, 2016298.92148.45150.4811.677.75%3.9%—$1.54
FY 2016 Q2Jun 30, 2016336.96120.5216.4511.495.31%3.41%—$1.89
FY 2016 Q1Mar 31, 2016464.23127.21337.0113.23.92%2.84%—$1.93
FY 2015 Q4Dec 31, 2015224.4109.74114.669.838.57%4.38%—$1.74
FY 2015 Q3Sep 30, 2015264.999165.99.675.83%3.65%—$1.48
FY 2015 Q2Jun 30, 2015260.3381.3179.029.655.39%3.7%—$1.8
FY 2015 Q1Mar 31, 2015271.2889.2818210.835.95%3.99%—$1.73
FY 2014 Q4Dec 31, 2014346.3281.79264.538.383.17%2.42%—$1.71
FY 2014 Q3Sep 30, 2014231.14122.58108.567.777.16%3.36%—$0.82
FY 2014 Q2Jun 30, 2014263.7894.4169.387.794.6%2.95%—$1.51
FY 2014 Q1Mar 31, 2014194.6492.39102.257.156.99%3.67%—$1.38
FY 2013 Q4Dec 31, 2013292.5178.74213.777.713.61%2.64%—$1.24
FY 2013 Q3Sep 30, 2013185.73103.8181.926.497.93%3.5%—$1.15
FY 2013 Q2Jun 30, 2013218.2480.03138.216.474.68%2.96%—$1.53
FY 2013 Q1Mar 31, 2013187.7695.9291.847.117.74%3.79%—$1.21
FY 2012 Q4Dec 31, 2012280.2781199.266.333.18%2.26%—$1.39
FY 2012 Q3Sep 30, 2012162.1499.8462.35.198.33%3.2%—$0.73
FY 2012 Q2Jun 30, 2012245.6489.79155.855.513.54%2.24%—$1.1
FY 2012 Q1Mar 31, 2012127.2292.5634.665.4915.83%4.31%—$1.31
Sources and calculations

Financial inputs from company filings. Last checked Oct 18, 2026. A dash means missing inputs or an undefined calculation.

Period changes use the preceding fiscal quarter or year. Percentage changes divide by the absolute prior value; a zero or missing baseline has no percentage change. Percentage metrics show changes in percentage points.

FCF subtracts reported cash capital investment. PPE purchases are preferred; the productive-assets fallback also includes software and intangibles. Acquisitions and noncash lease additions are excluded. EPS and weighted shares are not summed across quarters. Annual figures use annual reports.

SBC / FCF always uses FCF before SBC deduction; both SBC ratios compare amounts from the same period. A zero or negative cash-flow denominator is undefined, and values above 100% are retained.

Each reported nonnegative cash use / sum of available tracked nonnegative cash uses × 100. Missing categories are omitted, never set to zero. This is the composition of tracked uses, not a complete cash-flow reconciliation or a percentage of OCF. SBC is noncash and excluded. Negative amounts are excluded as reversals or net receipts; they are not converted to spending. Annual bars use reported annual amounts. Turning off a category hides its share without changing the denominator. Debt repayments prefer a reported aggregate, with long-term or convertible-only scope identified in the tooltip. Acquisitions are net of cash acquired. Dividend payments use the aggregate where reported, including dividend equivalents when part of that concept.

The SBC option subtracts reported share-based compensation from FCF as an economic-cost scenario. Missing SBC never becomes zero.

Market prices: Yahoo Finance · UHS, USD. Latest completed close Sep 25, 2026. Price data retrieved Sep 28, 2026.

Operating cash flow
Reported net cash provided by or used in operating activities.
Capital expenditures
Reported cash capital investment. Uses purchases of property, plant and equipment where disclosed; otherwise purchases of productive assets, which can also include software and intangibles. Excludes acquisitions and noncash lease additions.
Free cash flow
Operating cash flow − reported cash capital investment. PPE purchases are preferred; the productive-assets fallback also includes software and intangibles. Reflects the SBC option and can differ from issuer-defined FCF.
Stock-based compensation
Reported share-based compensation addback in the cash-flow statement. Missing disclosure is not treated as zero.
SBC / free cash flow
Reported share-based compensation / (operating cash flow − cash capital investment) × 100, for the same fiscal period. Always uses FCF before SBC deduction. Zero or negative FCF is undefined; values above 100% are retained.
SBC / operating cash flow
Reported share-based compensation / reported operating cash flow × 100, for the same fiscal period. Zero or negative operating cash flow is undefined. Unaffected by the SBC deduction scenario.
Software & intangible investment
Separately tagged payments for capitalized software under US GAAP, or purchases of intangible assets under IFRS. This optional disclosure is not inferred from total capex or deducted a second time from FCF.
Diluted EPS
Reported diluted earnings per share, normalized for recorded subsequent stock splits. Quarterly EPS is never subtracted from annual or YTD EPS.